project id: TCGA-CESC; case submitter id: TCGA-DS-A1OB; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 45; days to birth: -16685; days to death: 861; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1962; year of death: 2009; age at diagnosis: 16685; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1199; initial weight: 150.0; sample id: d664c261-6c5f-454d-b908-334dc2683a2b; sample submitter id: TCGA-DS-A1OB-01A; portion id: 92d0ea47-2131-4cf5-995a-10de1fb79352; portion submitter id: TCGA-DS-A1OB-01A-11; slide id: dced2292-a317-40af-b7fc-c19ac5067d5b; slide submitter id: TCGA-DS-A1OB-01A-01-TSA; percent lymphocyte infiltration: 50.0; percent monocyte infiltration: 5.0; percent necrosis: 10.0; percent neutrophil infiltration: 30.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;